Ultra-processed foods represent a category of industrially engineered products characterized by the extensive addition of fats, sugars, starches, salts, and chemical additives such as emulsifiers and preservatives. Examples include sodas, packaged snacks, and processed meats, which are stripped of their natural nutrient content. These foods introduce novel compounds foreign to human metabolism, potentially inducing adverse health outcomes. In contemporary American diets, UPFs constitute approximately 60% of caloric intake in adults and nearly 70% in children, highlighting their pervasive presence.

Prior epidemiological studies have established correlations between UPF consumption and hallmark components of metabolic syndrome, including obesity, hypertension, dyslipidemia, and insulin resistance. Moreover, UPF intake correlates with elevated levels of high sensitivity C-reactive protein, a biomarker indicative of systemic inflammation and a predictor of cardiovascular events. While these associations suggested a mechanistic link, direct evidence connecting UPFs to clinical cardiovascular outcomes remained scant, necessitating rigorous investigation.

The current study meticulously analyzed dietary and health data from 4,787 U.S. adults aged 18 and above, sampled between 2021 and 2023. Participants provided detailed 24-hour dietary recalls over two separate days, enabling researchers to quantify the proportion of daily caloric consumption derived from UPFs using an established classification system. Participants were stratified into quartiles based on their UPF intake, facilitating comparative risk assessments.

Cardiovascular disease was defined by self-reported medical history of myocardial infarction or cerebrovascular accident. The analysis controlled for confounding variables including age, sex, race and ethnicity, smoking status, and socioeconomic factors such as income. The mean age of this nationally representative cohort was 55 years, with women constituting 56% of the sample. After statistical adjustments, individuals in the highest quartile of UPF consumption manifested a 47% statistically significant increase in CVD risk relative to those in the lowest quartile.

These findings resonate profoundly within the broader public health context. The ubiquity of UPFs within the modern food supply, coupled with their insidious role in exacerbating cardiovascular risk, calls for urgent intervention. The researchers draw parallels to the historic trajectory of tobacco control, suggesting that widespread recognition and policy-driven reduction of UPFs may follow a similar albeit protracted path.

However, unlike tobacco, the challenges surrounding UPFs are compounded by their deep market penetration by multinational corporations and the embedded nature of these products within the food environment. Moreover, socioeconomic disparities create formidable barriers to accessing wholesome, nutrient-rich foods, necessitating policy frameworks that ensure equitable access and affordability of healthier options.

Dr. Charles H. Hennekens, lead author and senior academic advisor at the FAU Schmidt College of Medicine, emphasizes the dual imperative of individual behavioral change and structural transformation. Clinical practitioners are urged to integrate dietary counseling that highlights the deleterious cardiovascular impacts of UPFs, while public health initiatives must prioritize creating environments where nutritious foods are the default choice.

The implications extend beyond cardiovascular health. Co-author Dr. Allison H. Ferris highlights emerging evidence connecting UPFs with rising colorectal cancer incidences in younger populations. The shared risk factors between CVD and certain cancers underscore the multifaceted health burden attributable to UPF consumption.

While acknowledging the necessity for large-scale randomized controlled trials to conclusively establish causality and inform guidelines, the current evidence advises immediate action. Healthcare providers should advocate for reduced UPF consumption as part of comprehensive lifestyle modification strategies alongside pharmacological therapies with proven cardiovascular benefit.

This groundbreaking study integrates contributions from multidisciplinary scholars, including statistics experts and medical students, to illuminate a critical public health issue at the nexus of nutrition, chronic disease, and societal well-being. The data generated not only catalyze further research but also provide actionable insights for policy-makers, clinicians, and individuals alike.

In an era defined by escalating chronic disease prevalence, this research spotlights ultra-processed foods as a modifiable dietary factor with substantial cardiovascular repercussions. The path forward mandates concerted efforts to redefine food environments, empower consumers, and enact policies that prioritize human health over industrial profit.

Subject of Research: People
Article Title: Consumption of Ultra-Processed Foods and Increased Risks of Cardiovascular Disease in U.S. Adults
News Publication Date: 30-Jan-2026
Web References: https://www.amjmed.com/article/S0002-9343(26)00054-9/abstract
References: DOI: 10.1016/j.amjmed.2026.01.012
Image Credits: Florida Atlantic University

Keywords

Public health, diets, human health, foods, beverages, food chemistry, food additives, food preservatives, cardiovascular disorders, cardiac arrest, cardiovascular disease, heart disease, myocarditis, brain injuries, cerebrovascular disorders

Cancer survivors face persistent health challenges long after their initial diagnosis and treatment. Emerging evidence underscores the importance of holistic health evaluations beyond mere oncological parameters. The newly proposed LC9 score, an extension of the well-established Life’s Essential 8 (LE8), incorporates psychological health, particularly depression status, into cardiovascular risk assessment. This study is pioneering in its rigorous evaluation of LC9’s prognostic value, filling a crucial gap in survivorship research where psychological and cardiovascular factors have often been analyzed separately.

Utilizing a robust cohort of 2,558 adult cancer survivors tracked between 2005 and 2018, the investigators employed advanced statistical methodologies including Cox proportional hazards regression and restricted cubic spline modeling to scrutinize mortality risks. The LC9 score, calculated as the average of LE8 metrics and depression assessments, serves as an integrative indicator reflecting both physical and mental health dimensions. This multidimensional approach acknowledges the complex interplay between psychological well-being and cardiovascular functions in shaping long-term survival.

Over an average follow-up period exceeding six years, the study recorded 640 deaths, with nearly a third attributable to cancer and cardiovascular disease respectively. Notably, after comprehensive adjustment for potential confounders such as demographic variables, comorbidities, and lifestyle factors, each 10-point increment in LC9 was linked to a remarkable 24% decrease in all-cause mortality. This strong inverse correlation suggests that LC9 could serve as a potent predictive tool for survival prospects in cancer survivors, emphasizing that cardiovascular and psychological health are pivotal in determining longevity.

The study detailed more nuanced findings as well: cancer-specific mortality demonstrated a 19% reduction with improved LC9 scores, while cardiovascular mortality showed an even more pronounced 28% decrease. These results are indicative of the far-reaching impact that improvements in cardiovascular and mental health can have, potentially mediating not only cancer progression but also mitigating fatal cardiovascular events that frequently complicate survivorship care.

Kaplan-Meier survival analyses further elucidated these associations by graphically demonstrating stratified mortality rates based on LC9 quartiles. Participants with higher LC9 scores consistently exhibited superior survival probabilities across all examined categories. This visualization reinforces the critical message that survival disparities among cancer survivors can be meaningfully altered through targeted enhancements in cardiovascular and psychological domains.

Intriguingly, restricted cubic spline analyses identified differential dose-response patterns. While a linear inverse relationship was confirmed between LC9 and both all-cause and cancer-specific mortality, a nonlinear association emerged concerning cardiovascular mortality. This finding invites further inquiry into threshold effects or potential ceiling benefits regarding cardiovascular outcomes, implying that beyond a certain point, incremental LC9 improvements might yield diminishing returns, or that complex physiological mechanisms are at play.

The LC9 scoring system’s inclusion of depression metrics highlights the oft-overlooked psychological dimension intrinsic to survivorship health. Depression is prevalent among cancer survivors and has been independently associated with increased morbidity and mortality. Integrating mental health assessments into cardiovascular risk frameworks could therefore redefine prognostic stratification and intervention paradigms, prompting more holistic patient evaluations in clinical practice.

Importantly, this research delineates a clear translational pathway: interventions designed to enhance LC9 scores—whether through lifestyle modification, psychosocial support, pharmacotherapy, or comprehensive rehabilitation—may translate to tangible survival benefits. These findings advocate for integrative survivorship programs that simultaneously address cardiovascular risk factors and mental health, transcending conventional oncology-centric follow-up.

This study leverages the extensive NHANES database, renowned for its rigorous data collection and representativeness of the U.S. population, thus bolstering the generalizability of its conclusions. By spanning over a decade of surveillance, the analysis captures long-term mortality trends and mitigates temporal biases, providing robust evidence on the sustained influence of LC9 on survivorship outcomes.

From a public health perspective, the results resonate with the growing recognition of cardiovascular disease as a leading cause of death among cancer survivors, rivaling cancer recurrence itself. Traditionally, survivorship care has been compartmentalized, often prioritizing oncologic surveillance above cardiovascular management or psychological well-being. The LC9 framework challenges this paradigm, advocating a multifaceted approach to survivor health.

The study’s implications may extend beyond the realm of cancer survivorship. By validating the prognostic significance of integrating psychological well-being into cardiovascular health metrics, LC9 could inform risk stratification in broader clinical populations. The findings may catalyze revisions of clinical guidelines to incorporate psychological screening as a routine component of cardiovascular assessment.

Furthermore, the research underscores the intricate biological interconnections between mental health and cardiovascular functioning. Mechanistic pathways, including neuroendocrine regulation, autonomic nervous system modulation, and systemic inflammation, likely mediate these associations. Unraveling these mechanisms may spawn novel therapeutic targets aiming to concurrently improve psychological and cardiovascular resilience.

Despite its strengths, the study acknowledges limitations inherent to observational designs, including potential residual confounding and the challenge of causal inference. Further prospective studies and randomized controlled trials are warranted to validate LC9 as a modifiable risk factor and to test targeted interventions aimed at improving LC9 scores among cancer survivors.

In conclusion, this landmark study reveals that Life’s Crucial 9 score, integrating psychological and cardiovascular health dimensions, serves as a powerful predictor of reduced mortality risk in U.S. cancer survivors. Its evidence-based adoption in clinical practice could revolutionize survivorship care, fostering a holistic emphasis on mental and cardiovascular health as cornerstones of long-term survival and quality of life.

Subject of Research: The association of Life’s Crucial 9 (LC9) cardiovascular health score with all-cause, cancer-specific, and cardiovascular mortality in U.S. cancer survivors.

Article Title: The association between life’s crucial 9 and all-cause, cancer-specific and cardiovascular mortality in US cancer survivors: a cohort study of NHANES.

Article References:
Gong, H., Gao, M. & Zeng, Z. The association between life’s crucial 9 and all-cause, cancer-specific and cardiovascular mortality in US cancer survivors: a cohort study of NHANES. BMC Cancer 25, 805 (2025). https://doi.org/10.1186/s12885-025-14229-2

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14229-2